Literature DB >> 29741612

Reply to Elamin et al.

Anne M Lachiewicz1, David van Duin1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29741612      PMCID： PMC6117449          DOI： 10.1093/cid/ciy192

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

Review 1.  International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review.

Authors:  Robert Jan Hassing; Jelmer Alsma; Maris S Arcilla; Perry J van Genderen; Bruno H Stricker; Annelies Verbon
Journal:  Euro Surveill       Date:  2015

2.  Timeline of health care-associated infections and pathogens after burn injuries.

Authors:  David van Duin; Paula D Strassle; Lauren M DiBiase; Anne M Lachiewicz; William A Rutala; Timothy Eitas; Robert Maile; Hajime Kanamori; David J Weber; Bruce A Cairns; Sonia Napravnik; Samuel W Jones
Journal:  Am J Infect Control       Date:  2016-10-11       Impact factor: 2.918

3.  Multi-Drug Resistance in Burns Units-More Than Just a Burning Issue.

Authors:  Wael F Elamin; Sharon Weinberg; Catherine Spoors; Paul Roberts; Niall Martin; Peter Berry; Louise Teare
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 4.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

5.  A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center.

Authors:  Hajime Kanamori; Christian M Parobek; Jonathan J Juliano; David van Duin; Bruce A Cairns; David J Weber; William A Rutala
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Authors:  David van Duin; Judith J Lok; Michelle Earley; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Yohei Doi; Keith S Kaye; Vance G Fowler; David L Paterson; Robert A Bonomo; Scott Evans
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 7.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.

Authors:  Ilias Karaiskos; Helen Giamarellou
Journal:  Expert Opin Pharmacother       Date:  2014-04-28       Impact factor: 3.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.